Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W

Slides:

Advertisements

Similar presentations

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Advertisements

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Reply The Annals of Thoracic Surgery

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption Justin D. Blasberg, MD, Christopher W. Seder,

Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe Michelle C. Salazar, MD, Joshua E. Rosen, BASc,

Joshua E. Rosen, BASc, Hari B

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors Daniel J. Boffa, MD, Mark.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement After Lobectomy of the Lung Richard K. Freeman, MD, MBA, J. Russell Dilts,

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Quality Indicators for Non-Small Cell Lung Cancer Operations With Use of a Modified Delphi Consensus Process Gail Darling, MD, Richard Malthaner, MD,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Analyzing Effectiveness of Routine Pleural Drainage After Nuss Procedure: A Randomized Study Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski, MD, PhD, Piotr.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Surgical Lung Biopsy in Adult Respiratory Distress Syndrome: A Meta-Analysis Laura J. Libby, MD, Brian D. Gelbman, MD, Nasser K. Altorki, MD, Paul J.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Thomas J. Watson, MD, Jiejing Qiu, MS The Annals of Thoracic Surgery

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Daniel C. Thomas, MD, MPH, Justin D. Blasberg, MD, Brian N

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Michael G. Astudillo, BS, Andrew P. Dhanasopon, MD, Anthony W. Kim, MD

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Prognostic Differences in Subgroups of Patients With Surgically Resected T3 Non-Small Cell Lung Cancer Jae Hyun Jeon, MD, Moon Soo Kim, MD, Duk Hwan.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival Shuli Silberman, MD, Daniel Bitran, MD, Daniel.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

The Society of Thoracic Surgeons General Thoracic Surgery Database 2017 Update on Outcomes and Quality Christopher W. Seder, MD, Daniel P. Raymond, MD,

Niv Ad, MD, Sari D. Holmes, PhD, Deborah J

Mark W. Hennon, MD, Elisabeth U

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Bronchial Sleeve Resection Distal to the Main Bronchus With Complete Pulmonary Preservation for Benign or Low-Grade Malignant Tumors Xingtao Jiang, Xiaopeng.

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base

Presentation transcript:

Predictors of Mortality After Surgical Management of Lung Cancer in the National Cancer Database Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W. Kim, MD, Frank C. Detterbeck, MD, Daniel J. Boffa, MD The Annals of Thoracic Surgery Volume 98, Issue 6, Pages 1953-1960 (December 2014) DOI: 10.1016/j.athoracsur.2014.07.007 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Results of multivariable logistic regression modeling of 30-day mortality for 112,040 patients who underwent surgical resection for non-small cell lung cancer. ∗Other includes main bronchus tumors and those with unknown laterality. ∗∗Extended lobectomy (Ex Lobe/bilobectomy) includes procedures with chest wall, diaphragmatic, or pericardial resection, or procedures specified as extended, not otherwise specified. (CD = Charlson-Deyo; CI = confidence interval; cpy = cases per year; NOS = not otherwise specified.) The Annals of Thoracic Surgery 2014 98, 1953-1960DOI: (10.1016/j.athoracsur.2014.07.007) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Results of multivariable logistic regression modeling of extended length of stay (eLOS) for 73,502 patients who underwent lobectomy/bilobectomy for non-small cell lung cancer. ∗Other includes main bronchus tumors and those with unknown laterality. (CD = Charlson-Deyo; CI = confidence interval; cpy = cases per year; NOS = not otherwise specified.) The Annals of Thoracic Surgery 2014 98, 1953-1960DOI: (10.1016/j.athoracsur.2014.07.007) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions